Acute kidney injury (AKI) is a major complication of
sepsis.
Nucleotide-binding domain-like receptor
protein 3 (NLRP3)
inflammasomes are
multiprotein complexes that mediate septic AKI.
L-arginine (Arg) is a conditionally
essential amino acid in catabolic conditions and a substrate for
nitric oxide (NO) production; however, its use in
sepsis is controversial. This study investigated the effect of intravenous Arg supplementation on modulating NLRP3
inflammasome activity in relation to septic AKI. Mice were divided into normal control (NC),
sham,
sepsis saline (SS), and
sepsis Arg (SA) groups. In order to investigate the role of NO, L-N6-(1-iminoethyl)-lysine hydrochloride (L-NIL), an inducible
NO synthase inhibitor, was administered to the
sepsis groups.
Sepsis was induced using cecal
ligation and
puncture (CLP). The SS and SA groups received saline or Arg via tail vein 1 h after CLP. Mice were sacrificed at 6, 12, and 24 h after
sepsis. The results showed that compared to the NC group, septic mice had higher plasma kidney function parameters and lower Arg levels. Also, renal NLRP3
inflammasome protein expression and tubular injury score increased. After Arg treatment, plasma Arg and NO levels increased, kidney function improved, and expressions of renal NLRP3
inflammasome-related
proteins were downregulated. Changes in plasma NO and renal NLRP3
inflammasome-related
protein expression were abrogated when L-NIL was given to the Arg
sepsis groups. Arg plus L-NIL administration also attenuated kidney injury after CLP. The findings suggest that intravenous Arg supplementation immediately after
sepsis restores plasma Arg levels and is beneficial for attenuating septic AKI, partly via NO-mediated NLRP3
inflammasome inhibition.